Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cellular & Molecular Immunology

• Publication date

  2012-04-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/cmi.2012.5PMID 22543833PMCID PMC4012849
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• KIDNEYS.

  2020cited by this paper
• Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4

  2012cited by this paper
• HSP90 inhibition by 17-DMAG reduces inflammation in J774 macrophages through suppression of Akt and nuclear factor-κB pathways

  2012cited by this paper
• Histone Deacetylase 6 and Heat Shock Protein 90 Control the Functions of Foxp3+ T-Regulatory Cells

  2011cited by this paper
• EC144, a Synthetic Inhibitor of Heat Shock Protein 90, Blocks Innate and Adaptive Immune Responses in Models of Inflammation and Autoimmunity

  2011cited by this paper
• Heat-shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets.

  2011cited by this paper
• Dicer Insufficiency and MicroRNA-155 Overexpression in Lupus Regulatory T Cells: An Apparent Paradox in the Setting of an Inflammatory Milieu

  2011cited by this paper
• Amelioration of systemic lupus erythematosus by withangulatin A in MRL/lpr mice

  2011cited by this paper
• The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice.

  2011cited by this paper
• Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV.

  2011cited by this paper
• Targeted tumor necrosis factor receptor I preligand assembly domain improves skin lesions in MRL/lpr mice.

  2010cited by this paper
• Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects

  2010cited by this paper
• Revisiting anti-hsp90 antibodies in systemic lupus erythematosus.

  2010cited by this paper
• Phase I pharmacokinetic and pharmacodynamic study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an inhibitor of heat-shock protein 90, in patients with advanced solid tumors.

  2010cited by this paper
• Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.

  2010cited by this paper
• Identification of gp96 as a Novel Target for Treatment of Autoimmune Disease in Mice

  2010cited by this paper
• mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus?

  2010cited by this paper
• Folding of Toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperone

  2010cited by this paper
• B cells as therapeutic targets in SLE

  2010cited by this paper
• T cells as therapeutic targets in SLE

  2010cited by this paper
• C3a receptor deficiency accelerates the onset of renal injury in the MRL/lpr mouse.

  2009cited by this paper
• The atheroprotective properties of Hsp70: a role for Hsp70-endothelial interactions?

  2009cited by this paper
• Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.

  2009cited by this paper
• The busy life of regulatory T cells in systemic lupus erythematosus.

  2009cited by this paper
• The busy life of regulatory T cells in systemic lupus erythematosus.

  2009cited by this paper
• Hsp70 and cardiac surgery: molecular chaperone and inflammatory regulator with compartmentalized effects

  2009cited by this paper
• Update on Hsp90 inhibitors in clinical trial.

  2009cited by this paper
• The AKT axis as a therapeutic target in autoimmune diseases.

  2009cited by this paper
• Experimental anti-GBM nephritis as an analytical tool for studying spontaneous lupus nephritis

  2008cited by this paper
• 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.

  2008cited by this paper
• Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis.

  2008cited by this paper
• Targeting Hsp90: small-molecule inhibitors and their clinical development.

  2008cited by this paper
• Microarray analysis of glomerular gene expression in murine lupus nephritis.

  2008cited by this paper
• Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.

  2008cited by this paper
• 17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition.

  2008cited by this paper
• IL-6 Produced by Dendritic Cells from Lupus-Prone Mice Inhibits CD4+CD25+ T Cell Regulatory Functions1

  2007cited by this paper
• PI3K/AKT/mTOR hypersignaling in autoimmune lymphoproliferative disease engendered by the epistatic interplay of Sle1b and FASlpr.

  2007cited by this paper
• Hsp90: a novel target for the disruption of multiple signaling cascades.

  2007cited by this paper
• PI 3 K / AKT / mTOR hypersignaling in autoimmune lymphoproliferative disease engendered by the epistatic interplay of Sle 1 b and FASlpr

  2007cited by this paper
• Heat shock protein 90 inhibitors prolong survival, attenuate inflammation, and reduce lung injury in murine sepsis.

  2007cited by this paper
• Heat shock protein 90: The cancer chaperone

  2007cited by this paper
• Mesangial cells of lupus-prone mice are sensitive to chemokine production

  2007cited by this paper
• The heat‐shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein–Barr virus‐positive NK/T‐cell lymphoma by Akt down‐regulation

  2007cited by this paper
• Functional significance of hsp90 complexes with NOS and sGC in endothelial cells

  2007cited by this paper
• Cell stress induced HSP are targets of regulatory T cells: A role for HSP inducing compounds as anti‐inflammatory immuno‐modulators?

  2007cited by this paper
• Phenotypic and Functional Effects of Heat Shock Protein 90 Inhibition on Dendritic Cell

  2007cited by this paper
• Hsp90 inhibitors: Small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation

  2006cited by this paper
• Geldanamycin, an Inhibitor of Hsp90, Potentiates Cytochrome P4502E1-Mediated Toxicity in HepG2 Cells

  2006cited by this paper
• Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells

  2006cited by this paper
• The heat‐shock protein 90 inhibitor 17‐allylamino‐17‐demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis

  2006cited by this paper
• Geldanamycin , an Inhibitor of Hsp 90 , Potentiates Cytochrome P 4502 E 1-Mediated Toxicity in HepG 2 Cells

  2006cited by this paper
• Hsp70 inhibits lipopolysaccharide‐induced NF‐κB activation by interacting with TRAF6 and inhibiting its ubiquitination

  2006cited by this paper
• Heat shock proteins as emerging therapeutic targets

  2005cited by this paper
• In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative

  2005cited by this paper
• HSP90 and the chaperoning of cancer

  2005cited by this paper
• Cytokine expression in lupus kidneys

  2005cited by this paper
• PI3K/AKT signaling and systemic autoimmunity

  2005cited by this paper
• A Central Role for the Hsp90·Cdc37 Molecular Chaperone Module in Interleukin-1 Receptor-associated-kinase-dependent Signaling by Toll-like Receptors*

  2005cited by this paper
• T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells.

  2005cited by this paper
• B and T Cell antigen receptor repertoires in lupus/arthritis murine models

  2004cited by this paper
• Requirement of Hsp90 activity for IκB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-κB activation

  2004cited by this paper
• Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent

  2004cited by this paper
• Pharmacokinetics and pharmacodynamics of 17-demethoxy 17-[[(2-dimethylamino)ethyl]amino]geldanamycin (17DMAG, NSC 707545) in C.B-17 SCID mice bearing MDA-MB-231 human breast cancer xenografts

  2004cited by this paper
• Regulation of the Src Family Kinase Lck by Hsp90 and Ubiquitination

  2004cited by this paper
• Genetic basis of murine lupus.

  2004cited by this paper
• Strain Distribution Pattern of Susceptibility to Immune-Mediated Nephritis1

  2004cited by this paper
• Modulation of Renal Disease in MRL/lpr Mice by Suberoylanilide Hydroxamic Acid1

  2004cited by this paper
• Targeting multiple signal transduction pathways through inhibition of Hsp90

  2004cited by this paper
• Requirement of Hsp90 activity for IkappaB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-kappaB activation.

  2004cited by this paper
• Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain.

  2003cited by this paper
• Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases

  2003cited by this paper
• Heat Shock Protein 90 as an Endogenous Protein Enhancer of Inducible Nitric-oxide Synthase*

  2003cited by this paper
• Geldanamycin inhibits the production of inflammatory cytokines in activated macrophages by reducing the stability and translation of cytokine transcripts.

  2003cited by this paper
• Distinct Pathways for NF-κB Regulation Are Associated with Aberrant Macrophage IL-12 Production in Lupus- and Diabetes-Prone Mouse Strains1

  2003cited by this paper
• Hsp90 binds CpG oligonucleotides directly: implications for Hsp90 as a missing link in CpG signaling and recognition

  2003cited by this paper
• IL-12 Deficiency in MRL-Faslpr Mice Delays Nephritis and Intrarenal IFN-γ Expression, and Diminishes Systemic Pathology1

  2003cited by this paper
• Lupus‐specific kidney deposits of HSP90 are associated with altered IgG idiotypic interactions of anti‐HSP90 autoantibodies

  2002cited by this paper
• Hsp90 inhibitors as novel cancer chemotherapeutic agents.

  2002cited by this paper
• Genetic Dissection of Systemic Lupus Erythematosus Pathogenesis: Evidence for Functional Expression of Sle3/5 by Non-T Cells1

  2002cited by this paper
• IFNgamma induces functional chemokine receptor expression in human mesangial cells.

  2002cited by this paper
• Binding of ATP to Heat Shock Protein 90

  2002cited by this paper
• IFNγ induces functional chemokine receptor expression in human mesangial cells

  2002cited by this paper
• The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity

  2001cited by this paper
• Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1

  2001cited by this paper
• Elevated levels of the 90 kDa heat shock protein (hsp90) in SLE correlate with levels of IL-6 and autoantibodies to hsp90.

  2001cited by this paper
• Prostaglandin J(2) inhibition of mesangial cell iNOS expression.

  2001cited by this paper
• Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats

  2001cited by this paper
• Complement Component C3 Is Not Required for Full Expression of Immune Complex Glomerulonephritis in MRL/lpr Mice

  2001cited by this paper
• Increased Excretions of β2-Microglobulin, IL-6, and IL-8 and Decreased Excretion of Tamm-Horsfall Glycoprotein in Urine of Patients with Active Lupus nephritis

  2000cited by this paper
• The central and multiple roles of B cells in lupus pathogenesis

  1999cited by this paper
• Correlation of serum measures of nitric oxide production with lupus disease activity.

  1999cited by this paper
• Mechanisms and genetics of autoimmunity.

  1998cited by this paper
• Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice.

  1998cited by this paper
• IL‐6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice

  1998cited by this paper
• Mechanisms and Genetics of Autoimmunity a

  1998cited by this paper
• B cells and autoantibodies in the pathogenesis of lupus nephritis

  1998cited by this paper
• Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis.

  1998cited by this paper
• Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA.

  1995cited by this paper
• Lupus in the Fas Lane?

  1995cited by this paper
• Increased levels of antibodies to heat shock proteins with increasing age in Mrl/Mp-lpr/lpr mice.

  1995cited by this paper

• Molecular stratification and transcriptome-guided therapeutics in systemic lupus erythematosus with insufficient treatment response.

  2026cites this paper
• Immune cell senescence in autoimmunity: implications for disease pathogenesis and therapeutic targeting

  2025cites this paper
• Anti‐HSP90α IgG may protect against antiphospholipid syndrome in systemic lupus erythematosus by reducing platelet activation

  2025cites this paper
• HSP90 inhibitors beyond oncology: optimization and mechanism insights in non-oncological diseases.

  2025cites this paper
• Activation of IRF2 signaling networks facilitates podocyte pyroptosis in lupus nephritis.

  2025cites this paper
• Mechanisms of Rehmannioside A Against Systemic Lupus Erythematosus Based on Network Pharmacology, Molecular Docking and Molecular Dynamics Simulation

  2024cites this paper
• Hspa13 Deficiency Impaired Marginal Zone B Cells Regulatory Function and Contributed to Lupus Pathogenesis

  2024cites this paper
• Complex immunotoxic effects of T-2 Toxin on the murine spleen and thymus: Oxidative damage, inflammasomes, apoptosis, and immunosuppression.

  2024cites this paper
• Acacetin alleviates rheumatoid arthritis by targeting HSP90 ATPase domain to promote COX-2 degradation.

  2024cites this paper
• HSP90AB1’s effect on hepatocellular carcinoma’s local immune response and prognosis

  2024cites this paper
• Intraperitoneal Administration of 17-DMAG as an Effective Treatment against Leishmania braziliensis Infection in BALB/c Mice: A Preclinical Study

  2024cites this paper
• Unveiling the nexus: Decoding interactions between regulated cell death and systemic lupus erythematosus pathogenesis for innovative therapeutic avenues

  2024cites this paper
• Heat shock protein 90 inhibition attenuates inflammation in models of atopic dermatitis: a novel mechanism of action

  2024cites this paper
• Efficacy and Safety of the Heat Shock Protein 90 Inhibitor RGRN-305 in Hidradenitis Suppurativa

  2023cites this paper
• Heat shock protein 90 inhibitor RGRN-305 potently attenuates skin inflammation

  2023cites this paper
• Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy

  2023cites this paper
• Analysis of gene expression and use of connectivity mapping to identify drugs for treatment of human glomerulopathies

  2023cites this paper
• HSP90 Exacerbates Bone Destruction in Rheumatoid Arthritis by Activating TRAF6/NFATc1 Signaling

  2023cites this paper
• HSP90: A potential drug target in inflammatory skin diseases

  2023cites this paper
• Heat Shock Protein 90 (Hsp90) and Hsp70 as Potential Therapeutic Targets in Autoimmune Skin Diseases

  2022cites this paper
• Pathological mechanisms and crosstalk among different forms of cell death in systemic lupus erythematosus.

  2022cites this paper
• Integrating 3D genomic and epigenomic data to enhance target gene discovery and drug repurposing in transcriptome-wide association studies

  2022cites this paper
• Heat shock protein 90 is a new potential target of anti-rejection therapy in allotransplantation

  2022cites this paper
• Molecular Taxonomy of Systemic Lupus Erythematosus Through Data-Driven Patient Stratification: Molecular Endotypes and Cluster-Tailored Drugs

  2022cites this paper
• Advances in research related to heat shock protein 90 and autoimmune dermatoses

  2022cites this paper
• HSP90 inhibitor RGRN‐305 for oral treatment of plaque‐type psoriasis: efficacy, safety and biomarker results in an open‐label proof‐of‐concept study *

  2021cites this paper
• Role of HSP in the Pathogenesis of Age-Related Inflammatory Diseases

  2020cites this paper
• Heat shock protein 90 (Hsp90) Inhibitors: An Update on Achievements, Challenges, and Future Directions.

  2020cites this paper
• DNA vaccine encoding heat shock protein 90 protects from murine lupus

  2020cites this paper
• Extracellular Hsp90 Governs Spatio-Temporal Regulation of Biological Responses

  2019cites this paper
• Targeted cancer therapy through 17-DMAG as an Hsp90 inhibitor: Overview and current state of the art.

  2018cites this paper
• Heat shock protein 90 and inflammatory activity in newly onset Crohn’s disease

  2018cites this paper
• HSPs - Ambiguous Mediators of Immunity

  2017cites this paper
• Effect of curcumin on acute spinal cord injury in mice via inhibition of inflammation and TAK1 pathway

  2017cites this paper
• Heat Shock Proteins: Therapeutic Perspectives in Inflammatory Disorders.

  2017cites this paper
• Heat shock protein 90 is involved in IL-17-mediated skin inflammation following thermal stimulation.

  2016cites this paper
• Spatiotemporal Regulation of Hsp90–Ligand Complex Leads to Immune Activation

  2016cites this paper
• Heat shock proteins in the kidney

  2016influential citation
• Heat shock protein 90, a potential biomarker for type I diabetes: mechanisms of release from pancreatic beta cells

  2016influential citation
• Hsp90 inhibition ameliorates CD4+ T cell‐mediated acute Graft versus Host disease in mice

  2016cites this paper
• Selected novel aspects in pathogenesis of lupus erythematosus – interdisciplinary view

  2016cites this paper
• Selective histone deacetlyase inhibition decreases disease in lupus-prone mice

  2016cites this paper
• Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies

  2016cites this paper
• HEAT SHOCK PROTEINS: KNOWLEDGE SO FAR AND ITS FUTURE PROSPECTS

  2016cites this paper
• Single nucleotide polymorphisms of HSP90AA1 gene influence response of SLE patients to glucocorticoids treatment

  2016cites this paper
• Regulatory role of heat-shock proteins in autoimmune and inflammatory diseases

  2016cites this paper
• Heat shock protein 90 inhibition by 17-DMAG attenuates abdominal aortic aneurysm formation in mice.

  2015cites this paper
• Heat shock protein 90 (HSP90) and immune regulation

  2015cites this paper
• Heat shock protein 90 associates with Toll‐like receptors 7/9 and mediates self‐nucleic acid recognition in SLE

  2015cites this paper
• Heat shock protein 90 inhibition: A potential double- or triple-edged sword in the treatment of mucous membrane pemphigoid.

  2015cites this paper
• Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice

  2015cites this paper
• Short report Open Access

  2015cites this paper
• The HSP90 Inhibitor Ganetespib Alleviates Disease Progression and Augments Intermittent Cyclophosphamide Therapy in the MRL/lpr Mouse Model of Systemic Lupus Erythematosus

  2015cites this paper
• Targeting Heat-Shock Protein 90 (HSP90) as a Complementary Strategy to Immune Checkpoint Blockade for Cancer Therapy

  2015cites this paper
• Heat shock protein 90: a pathophysiological factor and novel treatment target in autoimmune bullous skin diseases

  2015cites this paper
• HSP90 inhibitors decrease AID levels and activity in mice and in human cells

  2015cites this paper
• Isoform-Selective HDAC Inhibition in Autoimmune Disease

  2014cites this paper
• Hsp90 blockade modulates bullous pemphigoid IgG-induced IL-8 production by keratinocytes

  2014cites this paper
• Inhibitory effects of heat shock protein 90 blockade on proinflammatory human Th1 and Th17 cell subpopulations

  2014cites this paper
• Hsp90: a chaperone for HIV-1

  2014cites this paper
• Immunomodulatory effects of heat shock protein 90 inhibition on humoral immune responses

  2014cites this paper
• Aberrant Expression and Secretion of Heat Shock Protein 90 in Patients with Bullous Pemphigoid

  2013cites this paper
• Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease

  2013cites this paper
• LPS induces pp60c‐srcmediated tyrosine phosphorylation of hsp90 in lung vascular endothelial cells and mouse lung

  2013cites this paper
• Role of Hsp90 in Systemic Lupus Erythematosus and Its Clinical Relevance

  2012cites this paper
• Heat Shock Proteins: Pathogenic Role in Atherosclerosis and Potential Therapeutic Implications

  2012cites this paper
• INTEGRATION OF HSP90 INHIBITION IN COMBINATIONAL IMMUNOTHERAPIES TARGETING RECEPTOR TYROSINE KINASE EPHA2

  2012cites this paper